Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001809519-24-000139
Filing Date
2024-07-10
Accepted
2024-07-10 17:21:49
Documents
4
Period of Report
2024-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1720646501.html 3  
1 FORM 3 wk-form3_1720646501.xml 3 1610
2 EX-24 exhibit24-poa_clark.htm EX-24 4566
3 exhibit24-poa_clark001.jpg GRAPHIC 222113
4 exhibit24-poa_clark002.jpg GRAPHIC 32928
  Complete submission text file 0001809519-24-000139.txt   358998
Mailing Address SOLAZYME, INC. 225 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
CLARK IAN T (Reporting) CIK: 0001336504 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39549 | Film No.: 241110606

Mailing Address 2701 OLYMPIC BOULEVARD SANTA MONICA CA 90404
Business Address 2701 OLYMPIC BOULEVARD SANTA MONICA CA 90404 (855) 268-2822
GoodRx Holdings, Inc. (Issuer) CIK: 0001809519 (see all company filings)

EIN.: 475104396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7374 Services-Computer Processing & Data Preparation
(CF Office: 06 Technology)